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Expression of Hemochromatosis in 
Homozygous Subjects 
Implications for Early Diagnosis and Prevention 
LAWRIE W. POWELL, KIM M. SUMMERS, PHILLIP G. BOARD, 
ELIZABETH AXELSEN, SONJA WEBB, and JUNE W. HALLIDAY 
Department of Medicine, University of Queensland, Brisbane, Australia; and The John Curtin 
School of Medical Research, Australian National University, Canberra, Australia 
This study looks at expression of genetic hemochro- 
matosis in the homozygous and heterozygous states. 
Two hundred nine subjects in 40 families with con- 
firmed hemochromatosis and clear evidence of HLA 
linkage in symptomatic individuals were studied 
prospectively for up to 24 yr. The study group 
consisted of 40 probands, 51 subjects sharing two 
HLA haplotypes with affected relatives (putative 
homozygotes), 98 putative heterozygotes, and 20 puta- 
tive normal homozygotes. Forty-eight of 51 subjects 
predicted to be homozygous showed increased he- 
patic iron stores as assessed by liver biopsy and 
quantitative phlebotomy. If not evident initially, this 
developed in l-8 yr. In the 3 subjects predicted by 
HLA typing to be homozygous but in whom there 
was no progressive iron accumulation, results of 
studies using another chromosome 6 genetic marker 
(Factor 13 A subunit) were consistent with chromo- 
somal recombination, presumably separating one 
hemochromatosis allele from the HLA markers. No 
heterozygous subject developed overt hemochroma- 
tosis during the period of follow-up, although 1 
showed evidence of iron overload at initial assess- 
ment. Genetic recombination is again thought to 
have separated the hemochromatosis allele from the 
HLA markers here. The present findings favor a 
location of the hemochromatosis locus telomeric to 
HLA-A. It is concluded that, in this population, 
hemochromatosis is apparently always HLA linked, 
and homozygous subjects will develop iron overload 
in the absence of chromosomal recombination or 
blood loss. 
H emochromatosis, an inherited disorder of iron rnetabolism characterized by progressive iron 
loading of parenchymal cells of the liver and other 
organs, is now known to be much more prevalent than 
was previously believed; recent estimates of the gene 
frequency in Caucasian populations have been as high 
as 120 (l-3). Moreover, patients diagnosed in the early 
precirrhotic stage of the disease and treated by phlebot- 
omy therapy have been shown to have a normal life 
expectancy, in contrast to cirrhotic patients who die 
from complications including liver failure and pri- 
mary hepatocellular carcinoma (J-6). 
Reports of a tight linkage between hemochromatosis 
and the human leukocyte antigen (HLAj-A locus on 
chromosome 6 (7-9) have led to clarification of the 
genetic nature and mode of inheritance of the disease 
and also the early identification of homozygous sub- 
jects (10-13). However, it is still unclear what propor- 
tion of subjects predicted to be homozygous for the 
disease alleles by HLA typing develop iron overload, a 
point with obvious implications for family screening 
and management. A further unanswered question is 
whether all hemochromatosis other than that caused 
by secondary iron overload in certain anemias is HLA 
related. 
This report describes the results of a prospective 
study of 40 families with hemochromatosis for up to 24 
yr to determine what proportion of putative homozy- 
gous subjects will eventually develop iron overload. 
Patients and Methods 
Subjects 
A total of 209 individuals from 40 families were 
studied with respect to hemochromatosis disease status and 
HLA type and followed up to 24 yr (median, 8 yr; range, l-24 
yr). The diagnosis of hemochromatosis in probands was 
made according to previously defined criteria (14). All 
available first- and second-degree relatives were investi- 
gated; in each instance, a clinical history was obtained and a 
physical examination was performed. Ethanol intake, iron 
Abbreviation used in this paper: F13A, Coagulation factor XIII 
A subunit. 
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medications, menstrual loss, blood donations, and other 
causes of chronic blood loss were recorded. Blood was 
drawn between 8 AM and 9 AM for the assessment of iron 
status and HLA typing. Percutaneous liver biopsy was 
performed in 98 subjects (40 probands and 58 relatives) in 
whom HLA typing indicated probable homozygosity for the 
disease or in whom either the transferrin saturation or the 
serum ferritin level was abnormal on more than one occa- 
sion. 
Determination of Iron Status 
Serum iron concentration, total iron-binding capac- 
ity, and transferrin saturation were determined according to 
standard techniques as previously described (15). Serum 
ferritin concentration was measured by a solid-phase immu- 
noradiometric assay [normal range, 20-200 pg/L for males 
and lo-150 /*g/L for females] (16). Serum ferritin was not 
measured before 1974, and values at diagnosis are therefore 
not available for subjects seen initially before this time. 
Liver biopsy sections were stained with H&E, a reticulin 
stain, and Perls’ Prussian blue stain for iron. The amount of 
stainable iron in hepatocytes was graded 0-4 (171, and 
hepatic iron concentration was measured on tissue dried to 
constant weight as previously described (18). The hepatic 
iron index was derived by dividing the hepatic iron concen- 
tration by the age in years at the time of biopsy (18). 
Increased iron stores were confirmed by quantitative phle- 
botomy in all homozygous subjects with evidence of iron 
overload. 
Genetic Markers on Chromosome 6 
Thirty-one HLA-A and HLA-B locus antigens were 
examined using the standard microlymphocytotoxicity test, 
and 10 HLA-DR antigens were tested in some families using 
the extended microcytotoxicity test on purified B lympho- 
cyte suspensions 119). In some instances, HLA-DR typing 
was defined by genotyping (20). 
Determination of coagulation factor XIII A (F13A) pheno- 
type was carried out by electrophoresis of plasma in agarose 
gels and specific staining as previously described (21). 
Assignment of Genotype in Family Members 
Results of previous studies by the authors (221 have 
shown that hemochromatosis is HLA-linked in symptomatic 
members of these families. Therefore, in each family the 
proband was assigned the status of homozygote, and each of 
the two HLA haplotypes identified in these subjects was 
assumed to be linked to a hemochromatosis allele. In 
families in which additional sibships showed evidence of 
disease, other HLA haplotypes associated with the disease 
were determined from the HLA type of affected individuals. 
Thus, for each family, two or more HLA haplotypes were 
disease linked. All family members could be classified on 
the basis of HLA typing as homozygous, with two disease- 
linked haplotypes (51 individuals], heterozygous, with one 
disease-linked haplotype (98 individuals], or homozygous 
normal, without disease-linked haplotypes (20 individuals]. 
HLA typing showed that homozygous-heterozygous mating 
had occurred at least 15 times. In each of these families, iron 
overload was present only in offspring carrying the same 
HLA haplotype from the unaffected (presumed heterozy- 
gous) parent. 
Prospective Evaluation 
All subjects were reviewed at predetermined inter- 
vals according to their hemochromatosis genotype as desig- 
nated using the HLA type as described above. Thus, all 
presumed homozygous subjects were reviewed every 6-12 
mo, heterozygous subjects were examined every 2 yr, and 
homozygous normal subjects were seen every 5 yr (13,15,23). 
This review was undertaken either by the authors or by a 
local physician. Liver biopsy was performed if there was a 
consistent increase in either the transferrin saturation or 
serum ferritin concentration. 
Results 
Probands 
All 40 probands had increased iron stores as 
assessed by one or more of the following (in the 
absence of known causes of secondary iron overload]: 
hepatic iron concentration >60 pmol/g dry weight 
(Figure 1); hepatic iron index >2 [18] (Figure 1); grade 3 
or 4 stainable iron in the liver (17); >5 g iron removed 
by quantitative phlebotomy: and urinary excretion of 
>2.2 mg iron after administration of 0.5 g desferrioxa- 
mine (24). There were 33 male and 7 female probands, 
the median ages at presentation being 41 yr (range, 
20-71 yr) for males and 38 yr (range, 18-74 yr) for 
females. This value for females is influenced by the 
presence of 2 young probands, aged 18 and 24 yr at 
presentation, with clear evidence of disease (hepatic 
iron concentrations of 128 and 74 pmol/g dry weight, 
respectively). Alcohol consumption was greater than 
50 g/day in 11 (34.4%) of the males and in 1 of the 
females. Twenty-six of the 40 probands were recorded 
as having symptoms relevant to hemochromatosis 
(hepatomegaly, diabetes, arthropathy, pigmentation, 
or testicular atrophy). Twelve probands had evidence 
of cirrhosis at biopsy, and 8 had evidence of fibrosis. 
As can be seen in Figure 1, all probands who had 
serum ferritin levels estimated had levels of greater 
than 200 pg/L at diagnosis but about one fifth had 
transferrin saturations of less than 6270, the value 
used by others (3) as being diagnostic of hemochroma- 
tosis. However, all probands with low transferrin 
saturations had high serum ferritin levels, ranging 
from 360 pg/L in a menstruating female to 4000 pg/L 
in an elderly male. All but 1 proband had grade 3 or 4 
stainable iron (Table 1); the single individual with 
grade 2 stainable iron was a young male. The hepatic 
iron index was greater than 2.5 in all probands except 
for 1 elderly female with an index of 1.9. Body iron 
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Figure 1. Indicators of iron status of probands and relatives at diagnosis of hemochromatosis (if affected) or at most recent assessment (if 
not affected); hh relatives, putative homozygous affected relatives; Hh relatives, putative heterozygous relatives: HH relatives, putative 
homozygous normal relatives; (0) males; (0) females: (b) median values. 
A. Serum ferritin levels. 
B. Serwn transferrin saturation. 
C. Hepatic iron concentration. 
D. Hepatic iron index. 
stores, as estimated from the amount of blood removed HLA haplotypes associated with hemochromatosis in 
before iron indices returned to normal levels, ranged their families were followed for a median of 5 yr 
from 3.5-56 g (median, 17; n = 20) in males and from (range, l-23 yr). The median age at first investigation 
3.5-49 g [median, 14; n = 6) in females, with the lower was 27.5 yr (range, 7-61 yr) in males and 33 yr (range, 
values being found in younger probands. 8-66 yr) in females. Iron indices at biopsy for this 
group are shown in Figure 1. Levels of serum ferritin, 
Putative Homozygous Relatives traniferrin saturation,kd hepatic iron concentration 
were widely scattered, with medians being lower than 
Twenty-eight male and 23 female relatives those for probands. A much broader spread was also 
predicted to be homozygous because they carried two seen in the amount of stainable iron detected [Table 1). 
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Table 1. Stainable Iron Graded at Liver Biopsy of 
Hemochromatosis Probands and Relatives 
Grade0 Grade1 Grade2 Grade3 Grade4 
Male probands 0 0 1 8 23 
Female probands 0 0 0 3 4 
Male hh relatives 0 0 5” 11 8 
Female hh rela- 
tives lb 3’ 2 9 3 
Male Hh relatives 0 3 3 Id 0 
Female Hh rela- 
tives 0 1 1 0 0 
hh Relatives, putative homozygous affected relatives: Hh relatives, 
putative heterozygous relatives. “Includes case 8 from Table 2. 
‘Case 15 from Table 2. “Includes case 14 from Table 2. dProbable 
recombinant; see Discussion. 
Alcohol consumption was greater than 50 g/day in 3 of 
17 males (17.6%) for whom information was available 
and in none of the females. Only 13 of the 51 putative 
homozygous relatives had symptoms relevant to hemo- 
chromatosis. Cirrhosis was found at two biopsies and 
fibrosis at three biopsies from this group. Of those for 
whom hepatic iron concentration was measured, 3 
had an hepatic iron index of less than 2. One of these, 
with an hepatic iron index of 1.7, is the sister of the 
female proband with an index of 1.9. The other two 
will be discussed. Body iron stores ranged from 2.5-25 
g [median, 6; n = 91 in males and from 1.8-12 g 
(median, 5; n = 6) in females. Again, the lower values 
were found in young subjects, including subjects 5 and 
6 in Table 2, who were aged 12 and 15 yr at diagnosis. 
Of the 51 subjects in this category, 35 showed clear 
evidence of increased iron stores on the first investiga- 
tion, whereas 16 had equivocal results on initial 
investigation. The relevant details of these 16 subjects 
are shown in Table 2. Eleven subjects developed 
evidence of increased iron stores during the period of 
observation, whereas one (patient 16) has not yet been 
fully assessed. 
Four putative homozygous subjects (patients 8, 13, 
14, and 15 in Table 2) did not manifest an increase in 
body iron stores during the period of prospective 
evaluation (4-13 yr). Subject 13 (II-3 in reference 25) 
was from a family that has been reported in detail 
previously (12). The development of increased iron 
stores in this subject was delayed because she suffered 
from severe inflammatory bowel disease, which re- 
sulted in her death in 1985 at age 50 yr. However, 
during a 2-yr period of remission of the bowel disease 
she manifested an increase in body iron stores [25), 
consistent with homozygosity for hemochromatosis. 
For the remaining three putative homozygous sub- 
jects who did not develop progressive iron overload 
(subjects 8, 14, and 15 in Table 21, one explanation 
would be genetic recombination resulting in separa- 
Table 2. Follow-up of Homozygous Relatives With Initial Equivocal Results 
Iron indices 
Initial At diagnosis” Hepatic iron 
Age ( yrl/ Periodof TS SF TS SF 
Body iron 
Concentration ~ 
Subject sex’ follow-upb (yr) (%) (r&ml) (%) (ng/mJ) Graded (pmol/gdrywt] Index’ Stores’ Comments 
1 21/F 49 36 190 48 
2 24/M 6 _h _h 33 
3 28/M 8 53 319 71 
4 10/M 3 43 49 62 
5 8/F 4 48 61 65 
6 11/F 4 64 72 73 
7 7/M a 51 66 71 
a 22/M 4 52 135 84 
9 26/F 1 58 304 62 
10 27/M 1 58 281 
11 19/M 2 73 57 
12 16/M 1 126 
13 42/F 7 27 31 46 
14 49/F 13 44 102 60 
15 72/F lok a5 30 50 
16 40/F 0.2 75 96 
465 
549 
560 
86 
100 
123 
149 
320’ 
280 
112 
29 
124 
580 
50 
141 
aa 
79 
32 
88 
35 
147 
75 
83 
5.6 
2.9 
2.2 
2.7 
- 
5.8 
1.4 
5.4 
2.7 
3.0 
0.81 
8.0 
2.5 
4.4 
2.3 
1.8 
2.0 
3.0 
NV 
5.0 
7.5 
6.0 
NV 
NV 
- 
Affected 
Affected 
Affected 
Affected 
Affected’ 
Affected’ 
Affected 
Recombinant 
Affected 
Affected 
Affected 
Affected 
Affected, IBD 
Recombinant 
Recombinant 
Bionsv nendine 
“Age at initial assessment. bFrom initial assessment to diagnosis of hemochromatosis or to most recent assessment if no evidence of iron 
overload. “Most recent value if no increase in iron stores. dMeasures hepatic parenchymal cell stainable iron, graded microscopically on a 
scale of O-4 (17). “Hepatic iron concentration divided by age in years (19). ‘Amount of iron removed by quantitative phlebotomy. 8This patient 
followed for 9 yr without evidence of disease before initial examination reported here. Early values not available. hInitial value unavailable; 
patient informed that he was normal. ‘Diagnosed before age 20 yr; iron stores high for age. ‘Values in this subject have fluctuated over the 4-yr 
period. At the time of liver biopsy, TS = 71% and SF = 250 pg/L. kThis patient was followed for 6 yr without evidence of disease, before 
initial examination reported here. Early values not available. TS, transferrin saturation: SF, serum ferritin concentration; NV, not venesected; 
IBD, inflammatory bowel disease. 
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tion of a hemochromatotic allele from the marker 
HLA Ihaplotype. In each HLA-identical sibling pair 
the F33A phenotypes were not identical, indicating 
that c‘hromosomal crossover had occurred between 
the HLA-A and F13A loci. These results are given in 
Table 3. In subject 15, aged 82 yr, evaluation over 16 yr 
(including 10 yr after normal liver biopsy results and 
repeated serological indices for iron storage) has indi- 
cated no increase in body iron stores during this 
period. Except for some angina pectoris, she remains 
well, with no evidence of iron overload. Genetic study 
of HLA and F13A markers in this family (Table 3) 
suggests that chromosome 6 recombination has caused 
the separation of one hemochromatosis allele from the 
HLA haplotype. This would be consistent with a 
location for the hemochromatosis disease locus be- 
tween HLA and F13A. Subject 14 has been evaluated 
prospectively over a period of 13 yr, including 4 liver 
biopsies with estimation of hepatic iron concentration 
(26). The most recent (March 1989) showed a hepatic 
iron concentration of 50 pmol/g dry weight at age 62 yr 
(hepatic iron index, 0.81. She shows no evidence of 
iron overload or progressive increase in iron stores. 
Segregation of F13A alleles in this family is also 
consistent with chromosomal recombination between 
F13A ;and HLA-DR loci (26). In subject 14, the recom- 
bination breakpoint would have been between HLA- 
DR and the hemochromatosis locus. Because of ho- 
mozygosity for HLA-A and HLA-B in a parent, it is not 
possible to determine in this family whether the 
hemochromatosis locus is telomeric or centromeric to 
HLA-.4. In subject 8 (Table 21, there was also evidence 
of chromosomal recombination (Table 3) and no pro- 
gressive increase in iron stores over the 4-yr period of 
follow-up, although the values for both serum ferritin 
and transferrin saturation have fluctuated from 135- 
366 pg/L and from 44% -84Y0, respectively. In this 
case, too, the hemochromatotic allele could have 
segregated with F13A, away from HLA-A, again local- 
izing the hemochromatotic gene telomeric to HLA-A. 
Table 3. Genetic Analysis of Predicted Homozygous 
Relatives Without Increased Iron Stores 
Index case Homozygous relative 
HLA F13A ID HLA F13A 
Family alleles alleles” no.h alleles alleles” 
1 Al B44 DR4 2-1 8 Al B44 DR4 l-l 
A3 B7 DR2 A3 B7 DR2 
2 A2 B12 DR4 l-l 14 A2 B12 DR4 2-1 
All B27 DR4 All B27 DR4 
3 A3 827 l-l 15 A3 B27 2-l 
All B35 All B35 
“As determined by F13A phenotyping (21). bAs listed in Table 2. ID, 
identification. 
Putative Heterozygous Relatives 
There were 98 subjects in this group, 49 males 
and 49 females, whose ages at first examination ranged 
from 13-70 yr (median, 42 yr) and 15-69 yr (median, 46 
yr), respectively. As shown in Figure 1, approximately 
one third (37/98) showed some phenotypic expression 
(elevated serum transferrin saturation and/or serum 
ferritin level] as has been found in previous studies 
(11,16,27). Twenty-five of these showed increased 
serum ferritin alone; 6 showed increases in both 
serum ferritin concentration and transferrin satura- 
tion. Alcohol consumption was greater than 50 g/day 
in 4 of 21 males (19%) and 1 of 25 females (4%) for 
whom we have this information. Thirteen putative 
heterozygous subjects whose serum ferritin concentra- 
tion or transferrin saturation was found to be in- 
creased on more than one occasion underwent liver 
biopsy; the median hepatic iron concentrations that 
were measured were 39.5 pmol/g dry weight (range, 
27-59 pmol/g) in 6 males and 48.4 /*mol/g dry weight 
(range, 28-63 pmol/g) in 4 females and with stainable 
iron ranging from grades l-3 (Table 1). Liver biopsy 
was not considered justified in those heterozygous 
subjects with normal transferrin saturation and serum 
ferritin levels, because previous studies in this and 
other centers have shown that if both these values are 
repeatedly normal, the probability of the subject hav- 
ing increased iron stores is virtually zero (13,281. Two 
female putative heterozygotes had iron stores calcu- 
lated to be 1.5 and 1.8 g after short periods of repeated 
phlebotomy. 
One subject in this group showed marginally in- 
creased iron stores based on the biopsy (hepatic iron 
concentration, 59 pmol/g dry weight; hepatic iron 
index, 1.1, stainable iron grade, 2), although a liver 
biopsy performed 10 yr earlier was normal without 
stainable iron. This subject is known to consume 
excessive alcohol, and his results are consistent with 
his being heterozygous for hemochromatosis with a 
small increase in iron stores associated with excessive 
alcohol consumption (29). An HLA-identical sister 
shows no signs of progressively increasing iron stores. 
A second putative heterozygote had substantial paren- 
chymal cell iron stores (grade 3) at biopsy at age 45 yr 
and iron stores of 8.3 g removed by repeated phlebot- 
omy. Thus, the latter patient had evidence of in- 
creased iron stores although sharing only one HLA 
haplotype with affected siblings. None of the other 96 
putative heterozygous subjects showed any evidence 
of increasing iron stores during the period of study. 
Putative Homozygous Normal Relatives 
Nine male and 10 female subjects designated 
homozygous normal by HLA typing showed normal 
transferrin saturation levels, although 4 males and 2 
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females showed increased levels of serum ferritin 
(Figure 1). None of these patients underwent liver 
biopsy. One male had a serum ferritin level of 540 
pg/L and a transferrin saturation of 55%, and a biopsy 
was performed. The hepatic iron concentration was 8 
pmol/g dry weight with a hepatic iron index of 0.3. At 
investigation, the age ranges of these subjects were 
20-72 yr (male) and 17-77 yr (female). During the 
period of follow-up, none of these has shown evi- 
dence of increasing iron stores. 
Discussion 
In this study of 40 families with hemochromato- 
sis, homozygosity for the disease as predicted by HLA 
typing was correlated with development of iron over- 
load in 47/50 individuals who have been investigated 
more than once. Amongst these were 11 individuals 
who developed evidence of increased iron stores 
during the period of observation and 1 [subject 13 in 
Table 1) who developed the disease only after control 
of intestinal blood loss. One of the 98 individuals 
predicted to be heterozygous for the disease by HLA 
typing had clear evidence of iron overload upon first 
assessment. No putative heterozygous subject devel- 
oped evidence of iron overload consistent with hemo- 
chromatosis during the period of follow-up. 
Three individuals (2 females and 1 male) who were 
HLA-identical to affected siblings and therefore pre- 
dicted to be homozygous for hemochromatosis showed 
no evidence of increased or increasing iron stores 
during periods of follow-up of from 4-16 yr when 
assessed by serial biochemical tests and multiple liver 
biopsies. Previous studies by the authors have indi- 
cated that homozygous subjects accumulate approxi- 
mately 0.5 g storage iron per yr and that this is 
reflected in their serum ferritin levels which increase 
by an average 65 pg/L per yr in the absence of blood 
loss (13). In contrast, subjects with only one abnormal 
allele do not develop progressive iron overload even 
though approximately 25% of them show some pheno- 
typic expression in the biochemical indices (11,151. 
The clinical picture of these 3 individuals is therefore 
like that of heterozygotes rather than homozygotes. 
There are several possible explanations for this 
result. First, it is possible that these 3 subjects repre- 
sent rare nonexpressing homozygotes. There is no 
evidence of overt or occult blood loss in the 2 females, 
both postmenopausal since ascertainment, or the young 
healthy male. In the face of distinctive and readily 
diagnosable disease in 47/5O putative homozygous 
individuals, including female siblings and subjects 
under 20 yr, this explanation seems unlikely. Although 
other investigators (11) have found that a proportion of 
female homozygotes do not express the expected 
clinical or laboratory phenotype of hemochromatosis, 
it is noteworthy that 43% (20/47) of the affected 
HLA-identical relatives are female, and that this is not 
significantly different from the proportion expected 
(50%) if males and females are equally likely to be 
affected (xl = 1.04; p = 0.3). 
A second possibility is that these families represent 
a rare form of hemochromatosis that is not HLA- 
linked. The worldwide association of hemochromato- 
sis with HLA-A3 in populations and with HLA haplo- 
types in families suggests that the same locus is 
involved in most or all cases. In 38 of the 40 families in 
this study the disease was clearly HLA-linked. In 
addition, data from the extended family of subject 14 
(family 23 in reference 221, including a second affected 
generation, indicate strong linkage with HLA in this 
family. The families of subjects 8 and 15 are small, and 
further pedigree analysis is not possible. However, in 
both cases, the HLA-A3 allele is found to be associated 
with the disease. Because this allele is in strong 
linkage disequilibrium with hemochromatosis in all 
populations studied (2,30), including our own (22), it 
seems likely that the disease in these two families is 
HLA-linked. This suggests that there is a single, 
HLA-linked, hemochromatosis locus, although it is not 
clear whether there are one or several disease alleles 
at this locus. 
A third explanation, supported by the present re- 
sults, is that chromosomal recombination had oc- 
curred to separate the hemochromatosis gene and the 
marker HLA allele in these cases. In all 3 cases, 
phenotyping of F13A indicated that chromosomal 
recombination had occurred involving the relevant 
region of chromosome 6. The F13A subunit gene has 
recently been mapped to bands 6~24-25 (311, placing it 
distal to HLA-A, and the genetic distance between 
HLA and F13A seems to be at least 20 centimorgans 
(32,33), which could span a physical distance of more 
than 20 million bases. This means that recombination 
between HLA-A and F13A would be expected to be 
quite common, especially in the maternal chromo- 
somes. However, if the hemochromatosis allele lies 
telomeric to HLA-A, a subset of such recombinants 
will in fact represent a crossover between the HLA 
markers and the hemochromatosis allele. This would 
explain the lack of expression of the disease in 
subjects 8, 14, and 15, who have HLA-identical but 
F13A-nonidentical affected siblings. The exact loca- 
tion of the hemochromatosis gene is as yet unknown, 
but the results in the families of subjects 8 and 15 
could argue that it lies between HLA-A and F13A. 
A further observation of interest in this study was 
that only 1 of 98 putative heterozygous subjects stud- 
ied for up to 23 yr showed evidence of increased iron 
stores, even when there was excessive alcohol con- 
sumption. In this group of heterozygotes, there was no 
clinical or histological evidence of iron overload, with 
only 1 having marginally increased hepatic iron con- 
June 1990 
centration. These data confirm earlier reports suggest- 
ing that hemochromatosis is not fully expressed unless 
two abnormal alleles are present, even with the 
addition of alcoholism or hemolytic anemias (26,34- 
36]. 
One individual who was predicted to be heterozy- 
gous showed clinical symptoms of hemochromatosis at 
initial investigation. This is unlikely to be caused by a 
homozygous-heterozygous mating, because if this were 
the case, HLA typing would predict the mother to be a 
homozygote, and she shows no signs of increasing iron 
stores or symptoms at age 84 yr (transferrin saturation, 
26%; serum ferritin concentration, 105 pg/L; excretion 
of 0.5 mg iron in 24 h after injection of 0.5 g of 
desferrioxamine). Linkage of hemochromatosis to HLA 
haplotype is indicated by examination of other af- 
fected members of this family (family 14 in reference 
22). If the hemochromatosis locus lies telomeric to 
HLA-A, this individual probably carries a recombi- 
nant haplotype, resulting from a cross-over between 
HLA-A and the hemochromatotic locus, This family 
was not informative for studies of Fl3A phenotype. 
Analysis of three families with apparent recombi- 
nants (the families of subjects 8 and 15 in Table 3 and 
of the predicted heterozygote discussed above) shows 
that the hemochromatotic allele can apparently be 
separated from the complete HLA haplotype by a 
chromosomal cross-over. This is consistent with the 
hypothesis that the hemochromatosis locus is telo- 
merit to HLA-A and therefore outside the HLA 
region. This location has been suggested by other 
authors (37). The result with subject 14 [Table 1) shows 
the hemochromatosis locus segregating away from 
HLA-DR, also consistent with the notion of a location 
close ‘to HLA-A, although not eliminating the possibil- 
ity of a location between HLA-A and HLA-B, as 
indicated by the results of Edwards et al. (38). Resolu- 
tion of these differences will come from analysis of 
further genetic markers in the critical region of chro- 
mosome 6 and ultimately from the molecular cloning 
of the gene or genes responsible for the disease. 
Approximately one fourth of heterozygotes and of 
homozygous normal individuals had increased serum 
ferritin levels, with transferrin saturation less than 
50~~1. ‘This is consistent with the results of our popula- 
tion study (1), which showed that an unexplained 
elevation of serum ferritin concentration above 300 
pg/L occurred in 172 of 704 males and 21 of 627 
females. The reasons for this are unclear but may 
relate to diet. The result for normal homozygotes 
shows that serum ferritin levels can be increased in 
the a‘bsence of any copies of the hemochromatosis 
gene. In addition, about one fifth of the patients had 
transferrin saturation levels of less than 62% in the 
presence of grossly increased parenchymal iron stores, 
as shown by biopsy, indicating that this value, which 
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has been used by others to discriminate homozygotes 
from heterozygotes (31, may be too high to detect all 
affected individuals. Because transferrin saturation 
values were not calculated after an overnight fast, it 
could be expected that some of the present values 
would be increased by dietary factors, but this does 
not explain the low values. 
In this study, fewer family members predicted to be 
homozygous for the normal allele at the hemochroma- 
totic locus were found than would be expected. This is 
probably the result of an ascertainment bias, because 
these studies have concentrated on families with more 
than one affected member in one or more generations, 
resulting in the inclusion of 15 confirmed homozygous- 
heterozygous matings. It should be noted that the 
population frequency of the hemochromatosis allele 
(l-3) is sufficiently high that at least 10% of known 
homozygotes will marry heterozygotes, with frequen- 
cies of affected and heterozygous offspring each of 
5070. 
This study has shown the practical clinical value of 
HLA typing in the management of families with 
hemochromatosis. HLA-identical siblings of affected 
individuals had lower hepatic iron concentrations and 
serum ferritin levels at diagnosis and were less likely 
to have irreversible liver damage. This illustrates the 
efficiency of obtaining HLA typing of siblings and 
initiating clinical investigation as early as possible to 
prevent serious complications. The distinction be- 
tween homozygotes, heterozygotes, and normal rela- 
tives is not otherwise possible in the early stages of the 
disease because the underlying metabolic defect has 
not yet been identified. Almost all individuals pre- 
dicted to be homozygous by HLA typing carry two 
hemochromatosis alleles and will develop progressive 
iron overload requiring phlebotomy therapy to main- 
tain body iron stores in the normal range. Relatives 
who have only one HLA haplotype identical to that in 
the proband have a low risk of developing iron 
overload. However, it is important to be aware that 
misclassification may occasionally occur, either be- 
cause of chromosomal recombination or a homozygous- 
heterozygous mating; hence, it is advisable to review 
putative heterozygotes at regular intervals of 2-3 yr. 
Relatives who have neither HLA haplotype identical 
to the proband can be reassured. that the risk of 
developing iron overload is negligible. 
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